Risk of pneumonia and pneumococcal disease in people hospitalized with diabetes mellitus: English record-linkage studies

Diabetic Medicine

Volumn 30, Issue 12, 2013, Pages 1412-1419

  Seminog, O O ^a   Goldacre, M J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; IMMUNIZATION; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; LOBAR PNEUMONIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PNEUMOCOCCAL INFECTION; PNEUMONIA; PRESCHOOL CHILD; RETROSPECTIVE STUDY; SCHOOL CHILD; STREPTOCOCCUS PNEUMONIA;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ENGLAND; FEMALE; HEALTH POLICY; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; VACCINATION;

EID: 84887627411     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/dme.12260     Document Type: Article

References (32)

1. Boyko EJ, Lipsky BA. Infection and diabetes. In: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennet PH, eds. Diabetes in America. 2nd ed. Bethesda, MD: National Institutes of Health, 1995; 485-499.
2. Department of Health, Joint Committee on Vaccination and Immunisation. Immunisation Against Infectious Disease. London: Her Majesty's Stationery Office (HMSO), 1992.
3. Pebody R, Hippisley-Cox J, Harcourt S, Pringle M, Painter M, Smith G. Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999-2005. Epidemiol Infect 2008; 136: 360-369.
4. Seminog O, Goldacre M. Risk of pneumonia and pneumococcal disease in people with severe mental illness: English record linkage studies. Thorax 2012; 68: 171-176.
5. Reynolds J, McDonald G, Alton H, Gordon S. Pneumonia in the immunocompetent patient. Br J Radiol 2010; 83: 998-1009.
6. Falguera M, Pifarre R, Martin A, Sheikh A, Moreno A. Etiology and outcome of community-acquired pneumonia in patients with diabetes mellitus. Chest 2005; 128: 3233-3239.
7. Melegaro A, Edmunds W, Pebody R, Miller E, George R. The current burden of pneumococcal disease in England and Wales. J Infect 2006; 52: 37-48.
8. Breslow N, Day N. Statistical methods in cancer research. Vol II. The design and analysis of cohort studies. IARC Sci Publ 1987; 82: 96-95.
9. Moss JM. Pneumococcus infection in diabetes mellitus. J Am Med Assoc 1980; 243: 2301-2303.
10. Muller L, Gorter K, Hak E, Goudzwaard W, Schellevis F, Hoepelman A, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis 2005; 41: 281.
11. Kornum J, Thomsen R, Riis A, Lervang H, Schønheyder H, Sørensen H. Type 2 diabetes and pneumonia outcomes. Diabetes Care 2007; 30: 2251-2257.
12. van Hoek A, Andrews N, Waight P, Stowe J, Gates P, George R, et al. The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease among hospitalised patients in England. J Infect 2012; 65: 17-24.
13. Shah B, Hux J. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003; 26: 510-513.
14. Marrie T. Bacteraemic pneumococcal pneumonia: a continuously evolving disease. J Infect 1992; 24: 247-255.
15. Shah B, Hux J. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003; 26: 510-513.
16. Peleg A, Weerarathna T, McCarthy J, Davis T. Common infections in diabetes: pathogenesis, management and relationship to glycaemic control. Diabetes Metab Res 2007; 23: 3-13.
17. Davis W, Knuiman M, Kendall P, Grange V, Davis T. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes. The Fremantle Diabetes Study. Diabetes Care 2004; 27: 752-757.
18. van den Borst B, Gosker H, Zeegers M, Schols A. Pulmonary function in diabetes. Chest 2010; 138: 393-406.
19. Hsia C, Raskin P. Lung function changes related to diabetes mellitus. Diabetes Technol Ther 2007; 9: 73-82.
20. Department of Health. Immunisation Against Infectious Disease: The Green Book. Part 2. Chapter 25, 2010. Available at https://www.gov.uk/government/publications/pneumococcal-the-green-book-chapter-25 Last accessed 14 August 2012.
21. Foster D, Walker A, Paul J, Griffiths D, Knox K, Peto T, et al. Oxford Invasive Pneumococcal Surveillance Group. Reduction in invasive pneumococcal disease following implementation of the conjugate vaccine in the Oxfordshire region, England. J Med Microbiol 2011; 60: 91-97.
22. Centers for Disease Control and Prevention. Indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005; 54: 893-897.
23. Klugman K, Chien Y, Madhi S. Pneumococcal pneumonia and influenza: a deadly combination. Vaccine 2009; 27: C9-C14.
24. Madhi S, Klugman K. A role for Streptococcus pneumoniae in virus-associated pneumonia. Nat Med 2004; 10: 811-813.
25. Grijalva C, Nuorti J, Arbogast P, Martin S, Edwards K, Griffin M. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. Lancet 2007; 369: 1179-1186.
26. Begum F, Pebody R. Vaccination Uptake Among the 65 Years and Over and Under 65 Years at Risk in England 2007-2008. Report for the Department of Health. Available at http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1213083216553 Last accessed 19 April 2013.
27. Melegaro A, Edmunds W. The 23-valent pneumococcal polysaccharide vaccine. Part I. Efficacy of PPV in the elderly: a comparison of meta-analyses. Eur J Epidemiol 2004; 19: 353-363.
28. Conaty S, Watson L, Dinnes J, Waugh N. The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials. Vaccine 2004; 22: 3214-3224.
29. Begum F, Pebody R. Pneumococcal Polysaccharide Vaccine (PPV) Uptake Report. Report for the Department of Health. 2012. Available at http://media.dh.gov.uk/network/211/files/2012/02/Pneumococcal-Vaccine-Uptake-Report-2009-2010-2011.pdf Last accessed 19 April 2013.
30. Moberley S, Holden J, Tatham D, Andrews R. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008; 1: CD000422.
31. Huss A, Scott P, Stuck A, Trotter C, Egger M. Efficacy of pneumococcal vaccination in adults: a meta-analysis. CMAJ 2009; 180: 48-58.
32. Moberley S, Torzillo P. Pneumococcal polysaccharide vaccine in high risk adults. Br Med J 2010; 340: c1139.